1. Home
  2. NBTX vs TBI Comparison

NBTX vs TBI Comparison

Compare NBTX & TBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NBTX
  • TBI
  • Stock Information
  • Founded
  • NBTX 2003
  • TBI 1985
  • Country
  • NBTX France
  • TBI United States
  • Employees
  • NBTX N/A
  • TBI N/A
  • Industry
  • NBTX Biotechnology: Pharmaceutical Preparations
  • TBI Professional Services
  • Sector
  • NBTX Health Care
  • TBI Consumer Discretionary
  • Exchange
  • NBTX Nasdaq
  • TBI Nasdaq
  • Market Cap
  • NBTX 167.8M
  • TBI 169.0M
  • IPO Year
  • NBTX 2020
  • TBI 1996
  • Fundamental
  • Price
  • NBTX $4.10
  • TBI $6.00
  • Analyst Decision
  • NBTX Strong Buy
  • TBI Buy
  • Analyst Count
  • NBTX 1
  • TBI 1
  • Target Price
  • NBTX $8.00
  • TBI $10.00
  • AVG Volume (30 Days)
  • NBTX 11.5K
  • TBI 525.7K
  • Earning Date
  • NBTX 04-02-2025
  • TBI 05-05-2025
  • Dividend Yield
  • NBTX N/A
  • TBI N/A
  • EPS Growth
  • NBTX N/A
  • TBI N/A
  • EPS
  • NBTX N/A
  • TBI N/A
  • Revenue
  • NBTX N/A
  • TBI $1,534,794,000.00
  • Revenue This Year
  • NBTX N/A
  • TBI $0.80
  • Revenue Next Year
  • NBTX $221.06
  • TBI $6.90
  • P/E Ratio
  • NBTX N/A
  • TBI N/A
  • Revenue Growth
  • NBTX N/A
  • TBI N/A
  • 52 Week Low
  • NBTX $2.76
  • TBI $3.45
  • 52 Week High
  • NBTX $7.29
  • TBI $12.29
  • Technical
  • Relative Strength Index (RSI)
  • NBTX 64.63
  • TBI 63.73
  • Support Level
  • NBTX $3.64
  • TBI $5.41
  • Resistance Level
  • NBTX $4.20
  • TBI $6.28
  • Average True Range (ATR)
  • NBTX 0.16
  • TBI 0.37
  • MACD
  • NBTX 0.04
  • TBI 0.10
  • Stochastic Oscillator
  • NBTX 88.51
  • TBI 84.70

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

About TBI TrueBlue Inc.

TrueBlue Inc is a provider of staffing and workforce management solutions. Its reportable segments include PeopleReady offers industrial staffing services. PeopleManagement offers contingent and productivity-based on-site industrial staffing services and PeopleScout offers recruitment process outsourcing, talent advisory services, and managed service provider services. It generates maximum revenue from the PeopleReady segment.

Share on Social Networks: